47 related articles for article (PubMed ID: 6838653)
1. Effects of erythromycin on hepatic drug-metabolizing enzymes in humans.
Larrey D; Funck-Brentano C; Breil P; Vitaux J; Theodore C; Babany G; Pessayre D
Biochem Pharmacol; 1983 Mar; 32(6):1063-8. PubMed ID: 6838653
[TBL] [Abstract][Full Text] [Related]
2. Irreversible Enzyme Inhibition Kinetics and Drug-Drug Interactions.
Mohutsky M; Hall SD
Methods Mol Biol; 2021; 2342():51-88. PubMed ID: 34272691
[TBL] [Abstract][Full Text] [Related]
3. Toxicity of erythromycin to Oncorhynchus mykiss at different biochemical levels: detoxification metabolism, energetic balance, and neurological impairment.
Rodrigues S; Antunes SC; Correia AT; Nunes B
Environ Sci Pollut Res Int; 2019 Jan; 26(1):227-239. PubMed ID: 30387066
[TBL] [Abstract][Full Text] [Related]
4. Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein.
Pinto AG; Horlander J; Chalasani N; Hamman M; Asghar A; Kolwankar D; Hall SD
Br J Clin Pharmacol; 2005 Apr; 59(4):440-6. PubMed ID: 15801939
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.
Zhou S; Yung Chan S; Cher Goh B; Chan E; Duan W; Huang M; McLeod HL
Clin Pharmacokinet; 2005; 44(3):279-304. PubMed ID: 15762770
[TBL] [Abstract][Full Text] [Related]
6. Exposure-response relationships and drug interactions of sirolimus.
Zimmerman JJ
AAPS J; 2004 Oct; 6(4):e28. PubMed ID: 15760093
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.
Pea F; Furlanut M
Clin Pharmacokinet; 2001; 40(11):833-68. PubMed ID: 11735605
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions.
Ohyama K; Nakajima M; Suzuki M; Shimada N; Yamazaki H; Yokoi T
Br J Clin Pharmacol; 2000 Mar; 49(3):244-53. PubMed ID: 10718780
[TBL] [Abstract][Full Text] [Related]
9. Inhibition and induction of cytochrome P450 and the clinical implications.
Lin JH; Lu AY
Clin Pharmacokinet; 1998 Nov; 35(5):361-90. PubMed ID: 9839089
[TBL] [Abstract][Full Text] [Related]
10. Liver cell models in in vitro toxicology.
Guillouzo A
Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):511-32. PubMed ID: 9599700
[TBL] [Abstract][Full Text] [Related]
11. Clinically significant drug interactions with cyclosporin. An update.
Campana C; Regazzi MB; Buggia I; Molinaro M
Clin Pharmacokinet; 1996 Feb; 30(2):141-79. PubMed ID: 8906896
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P-450 complex formation by dirithromycin and other macrolides in rat and human livers.
Lindstrom TD; Hanssen BR; Wrighton SA
Antimicrob Agents Chemother; 1993 Feb; 37(2):265-9. PubMed ID: 8452357
[TBL] [Abstract][Full Text] [Related]
13. Clarithromycin clinical pharmacokinetics.
Fraschini F; Scaglione F; Demartini G
Clin Pharmacokinet; 1993 Sep; 25(3):189-204. PubMed ID: 8222460
[TBL] [Abstract][Full Text] [Related]
14. A pharmacokinetic interaction between roxithromycin and midazolam.
Backman JT; Aranko K; Himberg JJ; Olkkola KT
Eur J Clin Pharmacol; 1994; 46(6):551-5. PubMed ID: 7995324
[TBL] [Abstract][Full Text] [Related]
15. The role of active metabolites in drug toxicity.
Pirmohamed M; Kitteringham NR; Park BK
Drug Saf; 1994 Aug; 11(2):114-44. PubMed ID: 7945999
[TBL] [Abstract][Full Text] [Related]
16. Macrolide antibacterials. Drug interactions of clinical significance.
von Rosensteil NA; Adam D
Drug Saf; 1995 Aug; 13(2):105-22. PubMed ID: 7576262
[TBL] [Abstract][Full Text] [Related]
17. Lack of clinically important interaction between erythromycin and theophylline.
Hildebrandt R; Gundert-Remy U; Möller H; Weber E
Eur J Clin Pharmacol; 1984; 26(4):485-9. PubMed ID: 6734707
[TBL] [Abstract][Full Text] [Related]
18. Identification of an inducible form of cytochrome P-450 in human liver.
Watkins PB; Wrighton SA; Maurel P; Schuetz EG; Mendez-Picon G; Parker GA; Guzelian PS
Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6310-4. PubMed ID: 3898085
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interactions of the macrolide antibiotics.
Ludden TM
Clin Pharmacokinet; 1985; 10(1):63-79. PubMed ID: 3882305
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin-erythromycin interaction in normal subjects.
Freeman DJ; Martell R; Carruthers SG; Heinrichs D; Keown PA; Stiller CR
Br J Clin Pharmacol; 1987 Jun; 23(6):776-8. PubMed ID: 3606938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
